Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
2 Months : From Oct 2019 to Dec 2019
By Michael Dabaie
Tandem Diabetes Care Inc. (TNDM) shares were up 10% to $62.14 in Tuesday morning trading.
Abbott Laboratories (ABT) and Tandem said Tuesday they would explore new integrated solutions for diabetes management.
The companies said they aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products.
Abbott shares were up 2% to $81.58.
Write to Michael Dabaie at email@example.com
(END) Dow Jones Newswires
October 15, 2019 10:30 ET (14:30 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.